YU36104A - Kristalna struktura fosfodiesteraza 5 i njihova upotreba - Google Patents
Kristalna struktura fosfodiesteraza 5 i njihova upotrebaInfo
- Publication number
- YU36104A YU36104A YU36104A YUP36104A YU36104A YU 36104 A YU36104 A YU 36104A YU 36104 A YU36104 A YU 36104A YU P36104 A YUP36104 A YU P36104A YU 36104 A YU36104 A YU 36104A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- pde5
- phosphodiesterase
- present
- crystal structure
- identifying
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/04—Phosphoric diester hydrolases (3.1.4)
- C12Y301/04035—3',5'-Cyclic-GMP phosphodiesterase (3.1.4.35)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Pharmacology & Pharmacy (AREA)
- Pathology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Cell Biology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Ovaj pronalazak se odnosi, inter alia na kristalne strukture fosfodiesteraza 5 (PDE5) i PDE5/PDE5 ligand komplekse i njihove upotrebe u identifikovanju PDE5 liganda, uključujući i PDE5 inhibitorska jedinjenja. Ovaj pronalazak se takodje odnosi na postupke za identifikaciju takvih PDE5 inhibitorskih jedinjenja i njihovu upotrebu u medicini. Ovaj pronalazak takodje razmatra i kristali PDE5/PDE5 inhibitor kompleksa.[The present invention relates , inter alia to the crystal structures of a phosphodiesterase 5 (PDE5) and PDE5/PDE5 ligand complex and their uses in identifying PDE5 ligands, including PDE5 inhibitor compounds. The present invention also relates to methods of identifying such PDE5 inhibitor compounds and their medical use. Also contemplated by the present invention are crystals of PDE5/PDE5 inhibitor complexes.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0126417.5A GB0126417D0 (en) | 2001-11-02 | 2001-11-02 | Crystal structure |
Publications (1)
Publication Number | Publication Date |
---|---|
YU36104A true YU36104A (sh) | 2006-08-17 |
Family
ID=9925082
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU36104A YU36104A (sh) | 2001-11-02 | 2002-10-24 | Kristalna struktura fosfodiesteraza 5 i njihova upotreba |
Country Status (13)
Country | Link |
---|---|
US (2) | US20070015205A1 (sh) |
EP (1) | EP1468082A1 (sh) |
KR (1) | KR20050039728A (sh) |
CN (1) | CN1585821A (sh) |
BR (1) | BR0213717A (sh) |
CA (1) | CA2478059A1 (sh) |
GB (1) | GB0126417D0 (sh) |
IL (1) | IL163926A0 (sh) |
PL (1) | PL370513A1 (sh) |
RU (1) | RU2301259C2 (sh) |
WO (1) | WO2003038080A1 (sh) |
YU (1) | YU36104A (sh) |
ZA (1) | ZA200403198B (sh) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2005133628A (ru) * | 2003-05-01 | 2007-05-10 | Пфайзер Инк. (US) | Кристалл pde5, его кристаллическая структура и применение для получения лекарственных средств |
EP1627323A4 (en) * | 2003-05-06 | 2008-04-09 | New Century Pharmaceuticals | ALBUMIN FIXATION SITES FOR EVALUATING DRUG INTERACTIONS OR THE DEVELOPMENT OF MEDICAMENTS BASED ON THEIR ALBUMIN BINDING PROPERTIES |
CA2585115A1 (en) * | 2003-11-03 | 2005-05-12 | New Century Pharmaceuticals, Inc. | Albumin binding sites for evaluating drug interactions and methods of evaluating or designing drugs based on their albumin binding properties |
CN101490099B (zh) * | 2006-07-12 | 2013-03-27 | 诺瓦提斯公司 | 用于制备隐形眼镜的可光化交联的共聚物 |
AR064286A1 (es) | 2006-12-13 | 2009-03-25 | Quiceno Gomez Alexandra Lorena | Produccion de dispositivos oftalmicos basados en la polimerizacion por crecimiento escalonado fotoinducida |
CN103865914B (zh) * | 2012-12-14 | 2016-05-25 | 上海美迪西生物医药股份有限公司 | Pde2催化结构域/pde2特异性抑制剂复合物的晶体及其生长方法 |
KR102141542B1 (ko) | 2013-12-31 | 2020-09-14 | 엘지디스플레이 주식회사 | 표시장치 |
FR3039297B1 (fr) * | 2015-07-20 | 2018-05-18 | Roam Data, Inc | Lecteur de carte compact |
KR102576402B1 (ko) | 2016-05-31 | 2023-09-11 | 엘지디스플레이 주식회사 | 액정표시장치 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1038963B1 (en) * | 1993-05-27 | 2009-08-05 | Board Of Regents Of The University Of Washington | Cyclic GMP-binding, cyclic GMP-specific phosphodiesterase materials and methods |
GB9923968D0 (en) * | 1999-10-11 | 1999-12-15 | Pfizer Ltd | Therapeutic agents |
PL356848A1 (en) * | 1999-12-24 | 2004-07-12 | Bayer Aktiengesellschaft | Novel imidazo[1,3,5]triazinones and the use thereof |
-
2001
- 2001-11-02 GB GBGB0126417.5A patent/GB0126417D0/en not_active Ceased
-
2002
- 2002-10-24 IL IL16392602A patent/IL163926A0/xx unknown
- 2002-10-24 RU RU2004113450/13A patent/RU2301259C2/ru not_active IP Right Cessation
- 2002-10-24 CA CA002478059A patent/CA2478059A1/en not_active Abandoned
- 2002-10-24 EP EP02775155A patent/EP1468082A1/en not_active Withdrawn
- 2002-10-24 CN CNA028266528A patent/CN1585821A/zh active Pending
- 2002-10-24 KR KR1020047006733A patent/KR20050039728A/ko not_active Application Discontinuation
- 2002-10-24 YU YU36104A patent/YU36104A/sh unknown
- 2002-10-24 US US10/415,839 patent/US20070015205A1/en not_active Abandoned
- 2002-10-24 BR BR0213717-8A patent/BR0213717A/pt not_active IP Right Cessation
- 2002-10-24 WO PCT/IB2002/004426 patent/WO2003038080A1/en not_active Application Discontinuation
- 2002-10-24 PL PL02370513A patent/PL370513A1/xx unknown
-
2003
- 2003-05-01 US US10/427,222 patent/US20040082052A1/en not_active Abandoned
-
2004
- 2004-04-28 ZA ZA200403198A patent/ZA200403198B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
US20040082052A1 (en) | 2004-04-29 |
RU2301259C2 (ru) | 2007-06-20 |
CN1585821A (zh) | 2005-02-23 |
US20070015205A1 (en) | 2007-01-18 |
KR20050039728A (ko) | 2005-04-29 |
GB0126417D0 (en) | 2002-01-02 |
BR0213717A (pt) | 2004-08-31 |
CA2478059A1 (en) | 2003-05-08 |
RU2004113450A (ru) | 2005-04-20 |
IL163926A0 (en) | 2005-12-18 |
ZA200403198B (en) | 2005-11-18 |
EP1468082A1 (en) | 2004-10-20 |
PL370513A1 (en) | 2005-05-30 |
WO2003038080A1 (en) | 2003-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9700430A (es) | El uso de compuestos heterociclicos. | |
CA2371818A1 (en) | Salicylamide-lanthanide complexes for use as luminescent markers | |
JO2311B1 (en) | Alkyl inhibitors Ariel phosphodiesterase-4 | |
MXPA04001348A (es) | NUEVOS COMPUESTOS DE FOSFITOS Y SUS COMPLEJOS METaLICOS. | |
HUP0302792A2 (hu) | Dipeptidil peptidáz ciklopropil-kondenzált pirrolidin-bázisú inhibitorai és eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények | |
EP1862457A3 (en) | Fluoropyrrolidines as dipeptidyl peptidase inhibitors | |
DE60016898D1 (de) | Phthalamid-lanthanid komplexe zur verwendung als lumineszenzmarker | |
ATE233762T1 (de) | Bicyclische polyamiosaure metallkomplexe, verfahren zu ihrer herstellung und ihre verwendung für medizinische bilderzeugung | |
DK0662972T3 (da) | 3-, 8-substituerede deuteroporphyrinderivater, farmaceutiske midler indeholdende disse og fremgangsmåder til deres fremstilling | |
GEP20084488B (en) | Use of therapeutic agents for treating pain | |
BG105784A (en) | Triazole compounds with dopamine-d3-receptor affinity | |
BR0210078A (pt) | Composto, uso do mesmo, e, formulação farmacêutica | |
PL373414A1 (en) | 8-methoxy-(1,2,4)triazolo(1,5-a)pyridine derivatives and their use as adenosine receptor ligands | |
WO2002062398A3 (en) | Radioactively labelled conjugates of phosphonates | |
IL133824A0 (en) | Tetrazole derivatives, medicaments containing same and use thereof | |
HK1063787A1 (en) | Novel ligand for nicotinic acetylcholine receptorsuseful in therapy | |
YU36104A (sh) | Kristalna struktura fosfodiesteraza 5 i njihova upotreba | |
CA2443285A1 (en) | Use of (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis | |
HUP0102615A2 (hu) | 2-(2-Klór-fenil)-3,4-dihidro-2H-pirrol-származékok | |
IL159993A0 (en) | Platinum complexes and their use in cancer treatment | |
RS20060239A (en) | Arylalkylcarbamate derivatives, preparation method thereof and use of same in therapeutics | |
WO2002013874A8 (de) | Verwendung von perfluoralkylhaltigen metallkomplexen als kontrastmittel im mr-imaging zur darstellung von plaques, tumoren und nekrosen | |
AU2001277549A1 (en) | Use of metal complexes containing perfluoroalkyl as contrast agents in mr-imaging for the representation of plaques, tumours and necroses | |
MXPA05010651A (es) | Compuestos de pirazol. | |
AU2003281146A1 (en) | Use of metal complexes containing perfluoroalkyl as contrast agents in mr-imaging for the representation of intravascular thrombes |